Matches in SemOpenAlex for { <https://semopenalex.org/work/W1703495064> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W1703495064 abstract "The pharmacokinetics and safety profile of JTE-522, 4-(4-cyclohexyl-2 methyloxazol-5-yl)-2-fluorobenzensulphonamide, a novel selective cyclooxygenase-2 inhibitor were investigated in healthy male volunteers.Initially, as a pilot study, five groups of two subjects were given oral doses of 3-100 mg of JTE-522. After safety assessment, subjects were given 150 and 200 mg of JTE-522. The effect of food-intake on the pharmacokinetics of JTE-522 at a dose of 150 mg was examined. In the multiple-dose study, subjects were given 150 mg of JTE-522 once a day for 7 days. Concentrations of unchanged JTE-522 in plasma, blood and urine were determined by high performance liquid chromatography (h.p.l.c.). Concentrations of metabolites were estimated with h.p.l.c. chromatograms and calibration curves for quantification of unchanged JTE-522.In the course of this study, no serious abnormality attributable to the test drug was observed, suggesting that JTE-522 was well tolerated in healthy subjects. In a single-dose study, the concentrations of JTE-522 in blood were much higher than the corresponding concentrations in plasma. JTE-522 was readily distributed to blood cells and percentage distribution into blood cells was more than 99.0%. However, the values of Cmax in blood at doses of 100, 150, 200 mg JTE-522 were 15241, 20445 +/- 3918 (16333-24556), 20965 +/- 3260 (17544-24386) ng ml-1, respectively. These findings suggest that JTE-522 has a high affinity for blood cells and the distribution into blood cells is limited at the higher doses of over 100 mg. In a multiple dose study, pharmacokinetic parameters including t1/2 and AUC after the fourth administration were comparable with that of the seventh administration. Thus, these findings suggest the absence of accumulation on the multiple-dosing of JTE-522.These results indicate that JTE-522 has an acceptable pharmacokinetic profile for clinical use without any serious adverse events as we verified in healthy young male volunteers." @default.
- W1703495064 created "2016-06-24" @default.
- W1703495064 creator A5008453611 @default.
- W1703495064 creator A5012000909 @default.
- W1703495064 creator A5037472971 @default.
- W1703495064 creator A5050298952 @default.
- W1703495064 creator A5072602785 @default.
- W1703495064 creator A5088804804 @default.
- W1703495064 date "2002-11-01" @default.
- W1703495064 modified "2023-09-23" @default.
- W1703495064 title "Pharmacokinetics and safety of JTE-522, a novel selective cyclooxygenase-2 inhibitor, in healthy male volunteers" @default.
- W1703495064 cites W1485442945 @default.
- W1703495064 cites W1536681507 @default.
- W1703495064 cites W160536334 @default.
- W1703495064 cites W1971304907 @default.
- W1703495064 cites W2000254391 @default.
- W1703495064 cites W2008574207 @default.
- W1703495064 cites W2037456194 @default.
- W1703495064 cites W2048152958 @default.
- W1703495064 cites W2049908664 @default.
- W1703495064 cites W2064145076 @default.
- W1703495064 cites W2078089623 @default.
- W1703495064 cites W2113745276 @default.
- W1703495064 doi "https://doi.org/10.1046/j.1365-2125.2002.01676.x" @default.
- W1703495064 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1874460" @default.
- W1703495064 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12445023" @default.
- W1703495064 hasPublicationYear "2002" @default.
- W1703495064 type Work @default.
- W1703495064 sameAs 1703495064 @default.
- W1703495064 citedByCount "2" @default.
- W1703495064 crossrefType "journal-article" @default.
- W1703495064 hasAuthorship W1703495064A5008453611 @default.
- W1703495064 hasAuthorship W1703495064A5012000909 @default.
- W1703495064 hasAuthorship W1703495064A5037472971 @default.
- W1703495064 hasAuthorship W1703495064A5050298952 @default.
- W1703495064 hasAuthorship W1703495064A5072602785 @default.
- W1703495064 hasAuthorship W1703495064A5088804804 @default.
- W1703495064 hasBestOaLocation W17034950642 @default.
- W1703495064 hasConcept C112705442 @default.
- W1703495064 hasConcept C126322002 @default.
- W1703495064 hasConcept C1621761 @default.
- W1703495064 hasConcept C179998833 @default.
- W1703495064 hasConcept C181199279 @default.
- W1703495064 hasConcept C185592680 @default.
- W1703495064 hasConcept C22979827 @default.
- W1703495064 hasConcept C2777056448 @default.
- W1703495064 hasConcept C2779689624 @default.
- W1703495064 hasConcept C2780026642 @default.
- W1703495064 hasConcept C43617362 @default.
- W1703495064 hasConcept C55493867 @default.
- W1703495064 hasConcept C71924100 @default.
- W1703495064 hasConcept C98274493 @default.
- W1703495064 hasConceptScore W1703495064C112705442 @default.
- W1703495064 hasConceptScore W1703495064C126322002 @default.
- W1703495064 hasConceptScore W1703495064C1621761 @default.
- W1703495064 hasConceptScore W1703495064C179998833 @default.
- W1703495064 hasConceptScore W1703495064C181199279 @default.
- W1703495064 hasConceptScore W1703495064C185592680 @default.
- W1703495064 hasConceptScore W1703495064C22979827 @default.
- W1703495064 hasConceptScore W1703495064C2777056448 @default.
- W1703495064 hasConceptScore W1703495064C2779689624 @default.
- W1703495064 hasConceptScore W1703495064C2780026642 @default.
- W1703495064 hasConceptScore W1703495064C43617362 @default.
- W1703495064 hasConceptScore W1703495064C55493867 @default.
- W1703495064 hasConceptScore W1703495064C71924100 @default.
- W1703495064 hasConceptScore W1703495064C98274493 @default.
- W1703495064 hasLocation W17034950641 @default.
- W1703495064 hasLocation W17034950642 @default.
- W1703495064 hasLocation W17034950643 @default.
- W1703495064 hasLocation W17034950644 @default.
- W1703495064 hasOpenAccess W1703495064 @default.
- W1703495064 hasPrimaryLocation W17034950641 @default.
- W1703495064 hasRelatedWork W1496303293 @default.
- W1703495064 hasRelatedWork W1531337498 @default.
- W1703495064 hasRelatedWork W1542271572 @default.
- W1703495064 hasRelatedWork W1588795846 @default.
- W1703495064 hasRelatedWork W1738847488 @default.
- W1703495064 hasRelatedWork W1848808867 @default.
- W1703495064 hasRelatedWork W1910330505 @default.
- W1703495064 hasRelatedWork W1934025460 @default.
- W1703495064 hasRelatedWork W2007684964 @default.
- W1703495064 hasRelatedWork W2028100587 @default.
- W1703495064 hasRelatedWork W2030756106 @default.
- W1703495064 hasRelatedWork W2055573745 @default.
- W1703495064 hasRelatedWork W2058282835 @default.
- W1703495064 hasRelatedWork W2061887424 @default.
- W1703495064 hasRelatedWork W2088299758 @default.
- W1703495064 hasRelatedWork W2106828783 @default.
- W1703495064 hasRelatedWork W2158868177 @default.
- W1703495064 hasRelatedWork W2413586587 @default.
- W1703495064 hasRelatedWork W2518349895 @default.
- W1703495064 hasRelatedWork W2568451129 @default.
- W1703495064 isParatext "false" @default.
- W1703495064 isRetracted "false" @default.
- W1703495064 magId "1703495064" @default.
- W1703495064 workType "article" @default.